Jul 12, 2017

Analysis: Expats and mental health Mental health is a growing issue for expats; workers and their employers, as well as those relocating independently, according to a recent research study by Aetna International. Expatriate mental health: breaking the silence and ending the stigma, calls for businesses and individuals to take more pre-emptive action to combat the problem, to ensure expats have the vital support they need when relocating or working away from their home country. Anaysis: How to improve outcomes for stroke patients in China A new programme, launched by the Chinese Stroke Association (CSA) and the American Stroke Association (ASA) is aiming to improve the treatment for, and prevention of, cardiovascular and stroke events by helping hospitals and providers consistently adhere to the latest scientific treatment guidelines. Analysis: Oventus pushes forward Brisbane-based Oventus has had a good week. First and foremost the sleep disorder device manufacturer has just completed the first tranche of capital raising. It has raised A$6.5 million (US$4.9 million) in a placement of shares at A$0.36 per share. A second tranche to raise A$0.5 million will follow subject to shareholder approval. Bell Potter is managing the deal. Analysis: The risk of regret A new report from QBE Insurance, Australia's largest global insurer, reveals that 22% of healthcare companies in Hong Kong have suffered from legal and regulatory compliance issues over the past 12 months. The Risks of Regret report looks at both current and future business challenges and opportunities, and how well-prepared companies are to deal with risks. Analysis: The opportunities of diabetes in Asia “The Asia-Pacific region presents lucrative opportunities for multinational pharmaceutical firms that treat diabetes,” says BMI Research in Singapore in a new report on healthcare in Asia. Fuelled by rapid urbanisation, nutrition transition and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity. Asia’s large population and rapid economic development have made it an epicentre of the epidemic, with India and China the key hotspots in the region, it explains.